Standalone and Consolidated Financial Results as on 31 March 2026.
TAKE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.9 pts more than Nifty Microcap 250 and 5.0 pts more than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Take Solutions reported strong consolidated financial performance for FY26 with total income of Rs.6,087 Lakhs, a robust 495.68% YoY growth driven by commencement of new operational activities (Revenue from Operations: Rs.5,419 Lakhs vs nil in FY25). The company posted consolidated net profit of Rs.1,085 Lakhs with EPS of Rs.0.74 per share. Standalone results showed a significant turnaround with net profit of Rs.272 Lakhs compared to a net loss of Rs.6,974 Lakhs in FY25. However, auditors issued a Qualified Opinion on both standalone and consolidated results due to unrecoverable income tax assets (standalone: Rs.876 Lakhs; consolidated: Rs.1,248 Lakhs) pending resolution of tax disputes before various appellate forums. This qualification has been repetitive since FY23. The auditors also highlighted an Emphasis of Matter confirming the company's going concern status following the divestment of Ecron Acunova Limited and clearing of debt obligations.
The strong revenue growth and return to profitability are positive signals for investors, but the persistent qualified auditor opinion on tax asset recoverability poses a risk of material impact if tax disputes are resolved unfavourably. Shareholders should monitor the outcome of pending tax litigations.